190 related articles for article (PubMed ID: 8567917)
1. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi.
Straubinger RK; Chang YF; Jacobson RH; Appel MJ
J Clin Microbiol; 1995 Oct; 33(10):2745-51. PubMed ID: 8567917
[TBL] [Abstract][Full Text] [Related]
2. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
Chang YF; Appel MJ; Jacobson RH; Shin SJ; Harpending P; Straubinger R; Patrican LA; Mohammed H; Summers BA
Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
Chang Y; Novosol V; McDonough SP; Chang CF; Jacobson RH; Divers T; Quimby FW; Shin S; Lein DH
Vaccine; 1999 Oct; 18(5-6):540-8. PubMed ID: 10519945
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM
Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
[TBL] [Abstract][Full Text] [Related]
5. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.
Kurtti TJ; Munderloh UG; Hughes CA; Engstrom SM; Johnson RC
Infect Immun; 1996 Oct; 64(10):4148-53. PubMed ID: 8926082
[TBL] [Abstract][Full Text] [Related]
6. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
de Silva AM; Telford SR; Brunet LR; Barthold SW; Fikrig E
J Exp Med; 1996 Jan; 183(1):271-5. PubMed ID: 8551231
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi.
Conlon JA; Mather TN; Tanner P; Gallo G; Jacobson RH
Vet Ther; 2000; 1(2):96-107. PubMed ID: 19757556
[TBL] [Abstract][Full Text] [Related]
8. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
Aydintug MK; Gu Y; Philipp MT
Infect Immun; 1994 Nov; 62(11):4929-37. PubMed ID: 7927774
[TBL] [Abstract][Full Text] [Related]
9. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.
Golde WT; Piesman J; Dolan MC; Kramer M; Hauser P; Lobet Y; Capiau C; Desmons P; Voet P; Dearwester D; Frantz JC
Infect Immun; 1997 Mar; 65(3):882-9. PubMed ID: 9038292
[TBL] [Abstract][Full Text] [Related]
10. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.
Tsao J; Barbour AG; Luke CJ; Fikrig E; Fish D
Vector Borne Zoonotic Dis; 2001; 1(1):65-74. PubMed ID: 12653137
[TBL] [Abstract][Full Text] [Related]
11. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
Eschner AK; Mugnai K
Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii.
Gern L; Hu CM; Voet P; Hauser P; Lobet Y
Vaccine; 1997 Oct; 15(14):1551-7. PubMed ID: 9330467
[TBL] [Abstract][Full Text] [Related]
13. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks.
de Silva AM; Zeidner NS; Zhang Y; Dolan MC; Piesman J; Fikrig E
Infect Immun; 1999 Jan; 67(1):30-5. PubMed ID: 9864192
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
[TBL] [Abstract][Full Text] [Related]
15. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
Coughlin RT; Fish D; Mather TN; Ma J; Pavia C; Bulger P
J Infect Dis; 1995 Apr; 171(4):1049-52. PubMed ID: 7706788
[TBL] [Abstract][Full Text] [Related]
16. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.
Wieneke CA; Lovrich SD; Callister SM; Jobe DA; Marks JA; Schell RF
J Clin Microbiol; 2000 Jan; 38(1):313-7. PubMed ID: 10618107
[TBL] [Abstract][Full Text] [Related]
18. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Wagner B; Freer H; Rollins A; Erb HN
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
Gern L; Rais O; Capiau C; Hauser P; Lobet Y; Simoen E; Voet P; Pêtre J
Immunol Lett; 1994 Mar; 39(3):249-58. PubMed ID: 8034340
[TBL] [Abstract][Full Text] [Related]
20. Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine.
Ma J; Hine PM; Clough ER; Fish D; Coughlin RT; Beltz GA; Shew MG
Vaccine; 1996 Oct; 14(14):1366-74. PubMed ID: 9004447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
